Ethanamine, 2-[[3-(3-methoxyphenyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]oxy]-

Catalog No. :
ACBWGK469
CAS No. :
1204298-34-9
Molecular Formula :
C14H15N5O2
Molecular Weight :
285.31

IUPAC Name:2-((3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)ethan-1-amine

Ethanamine, 2-[[3-(3-methoxyphenyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]oxy]- structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$289.00Login to see priceInquiryInquiry
1g98%$880.00Login to see priceInquiryInquiry
5g98%$2630.00Login to see priceInquiryInquiry
10g98%$3680.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthanamine, 2-[[3-(3-methoxyphenyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]oxy]-
IUPAC Name2-((3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)ethan-1-amine
Molecular FormulaC14H15N5O2
Molecular Weight285.31
SMILESCOC1=CC(C2=NN=C3C=CC(OCCN)=NN32)=CC=C1
InChI KeyMBFYXDMWEFUHLB-UHFFFAOYSA-N
Synonym(2-{[3-(3-methoxyphenyl)[1,2,4]triazolo[4,3-b]pyridazin-6-yl]oxy}ethyl)amine;2-((3-(3-Methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy)ethan-1-amine;(2-([3-(3-METHOXYPHENYL)[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-6-YL]OXY)ETHYL)AM+;Ethanamine, 2-[[3-(3-methoxyphenyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]oxy]-
CAS No.1204298-34-9

Synthetic Route by SureRoute

1. ACBWGK469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKTWL140 route compound structure diagram
    ACKTWL1402002-24-6 In Stock
  4. Then
  5. ACBWGK469 route product structure diagram
    ACBWGK4691204298-34-9
Inquiry

2. ACBWGK469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBWGK469 route product structure diagram
    ACBWGK4691204298-34-9
Inquiry

Comments (0)